Source: Annual Congress 2004 - Lung fibrosis sarcoidosis alveolar microlithiasis and proteinosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. A. Bazhanov, I. V. Dvorakovskaia, O. P. Baranova, A. T. Ivanov (St Petersburg, Russia). Whole lung lavage (WLL) for patients with pulmonary alveolar proteinosis. Eur Respir J 2004; 24: Suppl. 48, 4090

Member's Comments

No comment yet.

Related content which might interest you: Mini-whole lung lavage to treat pulmonary alveolar proteinosis (PAP) Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Whole lung lavage (WLL) in pulmonary alveolar proteinosis (PAP): long-term lung function follow-up Source: Eur Respir J 2001; 18: Suppl. 33, 220s Year: 2001 The benefits of whole lung lavage in pulmonary alveolar proteinosis Source: Eur Respir J 2004; 23: 503-505 Year: 2004 KL-6 in whole lung lavage fluid of patients with pulmonary alveolar proteinosis Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009 Determinants of protein concentration in whole lung lavage of patients with pulmonary alveolar proteinosis Source: Annual Congress 2009 - From genetics to clinics in diffuse parenchymal lung diseases Year: 2009 Pulmonary alveolar proteinosis Source: Respipedia Article Year: 2017 Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis Source: Eur Respir J 2004; 23: 526-531 Year: 2004 The value of the whole lung lavage for patients with pulmonaryalveolar proteinosis Source: Annual Congress 2009 - Trends in bronchoscopy Year: 2009 Lung function and symptom improvement in patients with pulmonary alveolar proteinosis after whole lung lavage or N-acetylcysteine treatment Source: Eur Respir J 2005; 26: Suppl. 49, 83s Year: 2005 Whole lung lavage with intermittent double lung ventilation: a new technique for managing pulmonary alveolar proteinosis Source: Eur Respir J 2004; 24: Suppl. 48, 91s Year: 2004 Long term follow up of the whole lung lavage programme in patients with pulmonary alveolar proteinosis: an update Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases Year: 2006 Pulmonary alveolar proteinosis: failure of treatment by bronchoscopic lobar lavages and GM-CSF treatment in a child Source: Eur Respir J 2003; 22: Suppl. 45, 309s Year: 2003 BAL cytology in pulmonary alveolar proteinosis: a review of 7 cases Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Idiopathic pulmonary alveolar proteinosis: GM CSF therapy and whole lung lavage a case report Source: Eur Respir J 2003; 22: Suppl. 45, 44s Year: 2003 Pulmonary alveolar proteinosis (PAP) - clinical features and response to treatment by bronchofiberoscopic lobar lavage Source: Eur Respir J 2005; 26: Suppl. 49, 541s Year: 2005 A gene network to predict the clinical response to whole lung lavage (WLL), in pulmonary alveolar proteinosis (PAP). Source: International Congress 2017 – Novel and old entities Year: 2017 Indication of whole lung lavage in pulmonary alveolar proteinosis – Retrospective study Source: International Congress 2015 – IIPs: orphan Year: 2015 Call for an international survey on therapeutic lavage for pulmonary alveolar proteinosis Source: Eur Respir J 2012; 39: 1049 Year: 2012 Pulmonary alveolar proteinosis and long-term outcome after bronchopulmonary lavage Source: International Congress 2017 – Paediatric bronchology Year: 2017 Therapeutic whole-lung lavage in alveolar proteinosis Source: Annual Congress 2008 - Trends in interventional pulmonology Year: 2008